Edit |   |
---|---|
Antigenic Specificity | C5 |
Clone | monoclonal |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | n/a |
Format | unconjugated |
Size | n/a |
Concentration | n/a |
Applications | ELISA, FC, IP, FuncS, IF, Neut, WB, |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human C5 Recombinant Antibody (Eculizumab). Recombinant monoclonal antibody to Human C5. Eculizumab also is the first agent approved for the treatment of atypical hemolytic uremic syndrome (aHUS), an ultra-rare genetic disease that causes abnormal blood clots to form in small blood vessels throughout the body, leading to kidney failure, damage to other vital organs and premature death. |
Immunogen | Human C5 protein emulsified with complete Fraud?s adjuvant |
Other Names | Eculizumab;soliris;219685-50-4;h5G1.1;DB01257 C5;complement component 5;complement C5;CPAMD4;anaphylatoxin C5a analog;C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4;FLJ17816;FLJ17822;MGC142298; |
Gene, Accession # | UniProt: P01031 |
Catalog # | TAB-008 |
Price | please inquire |
Order / More Info | C5 Antibody from CREATIVE BIOLABS, INC. |
Product Specific References | n/a |